Skip to content
Back to announcement

20251219_BMHS_Laporan Informasi dan Fakta Material_32014324_lamp1.pdf

Other Text extracted BMHS

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 3

Page 1 OCR 0.916
(@ bmhs

NW since 1973

No. : 679-K/PD/BMHS/XII/2025 Jakarta, 19 Desember 2025/ December 19", 2025

Lampiran/Att. : -
Perihal/ Re. : Keterbukaan Informasi Hasil Pelaksanaan MESOP PT Bundamedik Tbk (“Perseroan”)/
Disclosure of Information on the Results of MESOP Implementation of PT Bundamedik

Tbk (the “Company”)

Kepada Yth./To:

Otoritas Jasa Keuangan ("OJK")
Gedung Sumitro Djojohadikusumo

Jl. Lapangan Banteng Timur No. 2-4

Jakarta Pusat - 10710

U.p./Attn.To : Yth. Bapak I Gede Nyoman Yetna
Direktur Penilaian Perusahaan/

Director of Corporate Assessment

Dengan hormat,

Merujuk kepada Surat Perseroan Nomor 597-
K/PD/BMHS/X/2025 tanggal 27 Oktober 2025
perihal Informasi Rencana Periode Pelaksanaan
Tahap I Window Exercise II dan Tahap II Window
Exercise II Tahun 2025 Program Management
and Employee Stock Option Program (MESOP) PT
Bundamedik Tbk. Maka, sehubungan dengan
periode pelaksanaan MESOP pada tanggal 1
November 2025 sampai dengan tanggal 12
Desember 2025 dan sesuai dengan ketentuan
yang diatur dalam Surat Edaran BEI Nomor SE-
00002/BEI/03-2020, maka dengan ini Perseroan
menyampaikan keterbukaan informasi terkait

Yours faithfully,

Referring to the Company Letter 597-
K/PD/BMHS/X/2025 dated October 27”, 2025
regarding Information Planned
Implementation Period of Phase I Window
Exercise II and Phase II Window Exercise II of
2025 Program Management and Employee Stock
Option Program (MESOP) of PT Bundamedik Tbk.
Then in accordance to the implementation period
of the MESOP from November 15, 2025 to
December 12", 2025 and according to the
provisions stipulated in IDX Circular Letter
Number SE-00002/BEI/03-2020, the Company
hereby submit information disclosure related to

on

dengan hasil pelaksanaan MESOP sebagai the results of MESOP Implementation are as
berikut: follows:

No. Keterangan/Description Penjelasan/Explanation

bi Jumlah opsi yang telah dilaksanakan hak | O nihil/ none

konversinya dan jumlah saham baru yang telah
diterbitkan untuk periode pelaksanaan Tahap |
Window Exercise II/ The Number of options with
conversion rights that have been exercised and
number of new shares issued for the period of

Phase I Window Exercise II.
Jl. Teuku Cik Ditiro No. 11, Menteng -Jakarta Pusat 10350, Indonesia

Because Zanuils /Mattrs
www.bmhs.co.id @ 021-50980799 @

PT Bundamedik Tbk

Jl. Teuku Cik Ditiro No. 28, Menteng - Jakarta Pusat 10350, Indonesia
Head Office: BMHS Diagnos Tower 6" - 7" Floor
Page 2 OCR 0.922
(@ bmhs

4 since 1973

2x Jumlah opsi yang telah dilaksanakan hak | O nihil/ none
konversinya dan jumlah saham baru yang telah
diterbitkan untuk periode pelaksanaan Tahap II
Window Exercise II/ The Number of options with
conversion rights that have been exercised and
number of new shares issued for the period of
Phase II Window Exercise II.

3. Jumlah opsi yang belum dilaksanakan dan masih | 22.500.000 saham/ shares
berlaku untuk periode pelaksanaan Tahap 1
Window Exercise II / The number of options that
have not been exercised and are still valid for
the period of Phase I Window Exercise II.

4 Jumlah opsi yang belum dilaksanakan dan masih | 2.500.000 saham/ shares
berlaku untuk periode pelaksanaan Tahap II
Window Exercise II / The number of options that
have not been exercised and are still valid for
the period of Phase II Window Exercise II.

5. Jumlah saham MESOP yang belum dilaksanakan | O nihil/ none
dan habis masa berlakunya untuk periode
pelaksanaan Tahap I Window Exercise II / The
number of MESOP shares that have not been
exercised and expired for the period of Phase I
Window Exercise II.

6. Jumlah saham MESOP yang belum dilaksanakan | O nihil/ none
dan habis masa berlakunya untuk periode
pelaksanaan Tahap II Window Exercise II/ The
number of MESOP shares that have not been
exercised and expired for the period of Phase II
Window Exercise II.

3
PT Bundamedik Tbk

Jl. Teuku Cik Ditiro No. 28, Menteng - Jakarta Pusat 10350, Indonesia

Head Office: BMHS Diagnos Tower 6" - 7" Floor
Because Famili (are Jl. Teuku Cik Ditiro No. 11, Menteng - Jakarta Pusat 10350, Indonesia

www.bmhs.co.id @ 021-50980799 @

Ba AAA
Page 3 OCR 0.867
(@ bmhs

NN since 1973

Demikian keterbukaan informasi ini kami Hereby we convey this disclosure of information.
sampaikan. Atas perhatian dan kerjasamanya, Thank you for your attention and cooperation.
kami ucapkan terima kasih.

Hormat kami/Regards,

PT Bundamedik Tbk
Kg

Agus Heru Darjono

3 President Director

PT Bundamedik Tbk

Jl. Teuku Cik Ditiro No. 28, Menteng - Jakarta Pusat 10350, Indonesia
Head Office: BMHS Diagnos Tower 6" - 7" Floor

Because Famili er Jl. Teuku Cik Ditiro No. 11, Menteng -Jakarta Pusat 10350, Indonesia
www.bmhs.co.id @ 021-50980799 @

www

File

File Open PDF
Source IDX
Size1.0 MB
Published19 Dec 2025
Pages3
Characters4,668
Text sourceOCR
OCR confidence0.902

Names mentioned 5 people and organisations named in the text · linked when the evidence is strong

linked person Menteng -Jakarta Pusat p.1 ×6
linked person Agus Heru Darjono · 3 President Director p.3
possible org Bundamedik Tbk p.1 ×16
possible org Otoritas Jasa Keuangan p.1
unresolved person I Gede Nyoman Yetna p.1

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

Other files in this announcement 1

↑↓ select ↵ open ⇧↵ see every result